High-definition transcranial direct current stimulation (HD-tDCS) as augmentation therapy in late-life depression (LLD) with suboptimal response to treatment-a study protocol for a double-blinded randomized sham-controlled trial

Sze Ting Joanna Ngan, Lap Kei Chan, Wai Chi Chan, Linda Chiu Wa Lam, Wan Kei Li, Kelvin Lim, Ego Or, Pui Fai Pang, Ting Keung Poon, Mei Cheung Mimi Wong, Ying King Anna Wu, Pak Wing Calvin Cheng, Sze Ting Joanna Ngan, Lap Kei Chan, Wai Chi Chan, Linda Chiu Wa Lam, Wan Kei Li, Kelvin Lim, Ego Or, Pui Fai Pang, Ting Keung Poon, Mei Cheung Mimi Wong, Ying King Anna Wu, Pak Wing Calvin Cheng

Abstract

Background: Late-life depression (LLD) has a poorer prognosis and higher relapse rate than younger adults, with up to one third of patients with LLD showing suboptimal response to antidepressant therapy. LLD has been associated with significant impairment in cognition and daily functioning. Few studies have evaluated the therapeutic effects of high-definition transcranial direct current stimulation (HD-tDCS) on depressive and cognitive symptoms of LLD. The current randomized controlled trial assesses the efficacy of HD-tDCS as an augmentation therapy with antidepressants compared to sham-control in subjects with LLD.

Methods: Fifty-eight patients with LLD will be recruited and randomly assigned to the active HD-tDCS or sham HD-tDCS group. In both groups, patients will receive the active or sham intervention in addition to their pre-existing antidepressant therapy, for 2 weeks with 5 sessions per week, each lasting 30 min. The primary outcome measures will be the change of depressive symptoms, clinical response and the remission rate as measured with the Hamilton Depression Rating scale (HAMD-17) before and after the intervention, and at the 4th and 12th week after the completed intervention. Secondary outcome measures include cognitive symptoms, anxiety symptoms, daily functioning and adverse effects. DISCUSSION: Older adults with depression are associated with poorer outcomes or unsatisfactory responses to antidepressant therapy, and significant cognitive decline. Therefore, a new effective treatment option is needed. This randomized control trial aims at assessing the efficacy of HD-tDCS on ameliorating the depressive, cognitive and anxiety symptoms, and improving the daily functioning of subjects with LLD.

Trial registration: ClinicalTrials.gov NCT05322863. Registered on 11 April 2022.

Keywords: Augmentation therapy; High-definition transcranial direct current stimulation; Late-life depression.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Flowchart of the current study

References

    1. Mitchell AJ, Subramaniam H. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies. Am J Psychiatry. 2005;162(9):1588–1601. doi: 10.1176/appi.ajp.162.9.1588.
    1. Schatzberg A, Roose S. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression. Am J Geriatr Psychiatry. 2006;14(4):361–370. doi: 10.1097/01.JGP.0000194645.70869.3b.
    1. Nikolin S, Huggins C, Martin D, Alonzo A, Loo CK. Safety of repeated sessions of transcranial direct current stimulation: A systematic review. Brain Stimul. 2018;11(2):278–288. doi: 10.1016/j.brs.2017.10.020.
    1. Das S, Holland P, Frens MA, Donchin O. Impact of Transcranial Direct Current Stimulation (tDCS) on Neuronal Functions. Front Neurosci. 2016;10:550. doi: 10.3389/fnins.2016.00550.
    1. Fritsch B, Reis J, Martinowich K, Schambra HM, Ji Y, Cohen LG, et al. Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron. 2010;66(2):198–204. doi: 10.1016/j.neuron.2010.03.035.
    1. Homan P, Neumeister A, Nugent AC, Charney DS, Drevets WC, Hasler G. Serotonin versus catecholamine deficiency: behavioral and neural effects of experimental depletion in remitted depression. Transl Psychiatry. 2015;5(3):e532–e532. doi: 10.1038/tp.2015.25.
    1. Brunoni AR, Kemp AH, Shiozawa P, Cordeiro Q, Valiengo LC, Goulart AC, et al. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system. Eur Neuropsychopharmacol. 2013;23(11):1530–1540. doi: 10.1016/j.euroneuro.2013.03.009.
    1. Kuo HI, Paulus W, Batsikadze G, Jamil A, Kuo MF, Nitsche MA. Chronic Enhancement of Serotonin Facilitates Excitatory Transcranial Direct Current Stimulation-Induced Neuroplasticity. Neuropsychopharmacology. 2016;41(5):1223–1230. doi: 10.1038/npp.2015.270.
    1. Javadi AH, Walsh V. Transcranial direct current stimulation (tDCS) of the left dorsolateral prefrontal cortex modulates declarative memory. Brain Stimul. 2012;5(3):231–241. doi: 10.1016/j.brs.2011.06.007.
    1. Mulquiney PG, Hoy KE, Daskalakis ZJ, Fitzgerald PB. Improving working memory: exploring the effect of transcranial random noise stimulation and transcranial direct current stimulation on the dorsolateral prefrontal cortex. Clin Neurophysiol. 2011;122(12):2384–2389. doi: 10.1016/j.clinph.2011.05.009.
    1. Köhler S, Thomas AJ, Barnett NA, O'Brien JT. The pattern and course of cognitive impairment in late-life depression. Psychol Med. 2010;40(4):591–602. doi: 10.1017/S0033291709990833.
    1. Brunoni AR, Moffa AH, Fregni F, Palm U, Padberg F, Blumberger DM, et al. Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data. Br J Psychiatry. 2016;208(6):522–531. doi: 10.1192/bjp.bp.115.164715.
    1. Bares M, Brunovsky M, Stopkova P, Hejzlar M, Novak T. Transcranial Direct-Current Stimulation (tDCS) versus venlafaxine ER in the treatment of depression: a randomized, double-blind, single-center study with open-label. Follow-Up Neuropsychiatr Dis Treat. 2019;15:3003–3014. doi: 10.2147/NDT.S226577.
    1. Loo CK, Husain MM, McDonald WM, Aaronson S, O'Reardon JP, Alonzo A, et al. International randomized-controlled trial of transcranial Direct Current Stimulation in depression. Brain Stimul. 2018;11(1):125–133. doi: 10.1016/j.brs.2017.10.011.
    1. Doruk D, Gray Z, Bravo GL, Pascual-Leone A, Fregni F. Effects of tDCS on executive function in Parkinson's disease. Neurosci Lett. 2014;582:27–31. doi: 10.1016/j.neulet.2014.08.043.
    1. Alam M, Truong DQ, Khadka N, Bikson M. Spatial and polarity precision of concentric high-definition transcranial direct current stimulation (HD-tDCS) Phys Med Biol. 2016;61(12):4506–4521. doi: 10.1088/0031-9155/61/12/4506.
    1. Kuo HI, Bikson M, Datta A, Minhas P, Paulus W, Kuo MF, et al. Comparing cortical plasticity induced by conventional and high-definition 4 x 1 ring tDCS: a neurophysiological study. Brain Stimul. 2013;6(4):644–648. doi: 10.1016/j.brs.2012.09.010.
    1. Borckardt JJ, Bikson M, Frohman H, Reeves ST, Datta A, Bansal V, et al. A pilot study of the tolerability and effects of high-definition transcranial direct current stimulation (HD-tDCS) on pain perception. J Pain. 2012;13(2):112–120. doi: 10.1016/j.jpain.2011.07.001.
    1. Wong HL, Chan WC, Wong YL, Wong SN, Yung HY, Wong SC, et al. High-definition transcranial direct current stimulation-an open-label pilot intervention in alleviating depressive symptoms and cognitive deficits in late-life depression. CNS Neurosci Ther. 2019;25(11):1244–1253. doi: 10.1111/cns.13253.
    1. Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150(2):384–388. doi: 10.1016/j.jad.2013.04.028.
    1. Zheng YZJ, Phillips M, Liu J, Cai M, Sun S, Huang M. Validity and reliability of the Chinese Hamilton depression rating scale. Br J Psychiatry. 1988;152(5):660–664. doi: 10.1192/bjp.152.5.660.
    1. Wong A, Xiong YY, Kwan PW, Chan AY, Lam WW, Wang K, et al. The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dement Geriatr Cogn Disord. 2009;28(1):81–87. doi: 10.1159/000232589.
    1. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55. doi: 10.1111/j.2044-8341.1959.tb00467.x.
    1. Tong AY, Man DW. The validation of the Hong Kong Chinese version of the Lawton instrumental activities of daily living scale for institutionalized elderly persons. OTJR (Thorofare N J) 2002;22(4):132–142.
    1. Brunoni AR, Amadera J, Berbel B, Volz MS, Rizzerio BG, Fregni F. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int J Neuropsychopharmacol. 2011;14(8):1133–1145. doi: 10.1017/S1461145710001690.
    1. Gbadeyan O, Steinhauser M, McMahon K, Meinzer M. Safety, tolerability, blinding efficacy and behavioural effects of a novel MRI-compatible, high-definition tDCS set-up. Brain Stimul. 2016;9(4):545–552. doi: 10.1016/j.brs.2016.03.018.
    1. Kalu UG, Sexton CE, Loo CK, Ebmeier KP. Transcranial direct current stimulation in the treatment of major depression: a meta-analysis. Psychol Med. 2012;42(9):1791–1800. doi: 10.1017/S0033291711003059.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa